Nine years after the whistle first blew, AbbVie and Abbott Laboratories have finally settled a marketing investigation claiming they beefed up prescriptions for the heart drug TriCor by handing out kickbacks and touting it for unapproved use.
Nine years after the whistle first blew, AbbVie and Abbott Laboratories have finally settled a marketing investigation claiming they beefed up prescriptions for the heart drug TriCor by handing out kickbacks and touting it for unapproved use.
Pharmamarketeer richt zich op marketingprofessionals van farmaceuten en andere medisch-gerelateerde organisaties in Nederland en België.
Copyright 2023 © Uitgave van MedHealth Communications BV | Privacy disclaimer
![Hoe eenvoudige semantiek onze AI-citaties met 642% verhoogde [Nieuwe resultaten]](https://www.pharmamarketeer.nl/wp-content/uploads/2026/01/719-80x60.jpg)
Reageer